Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
NorthShore University HealthSystem, Evanston, Illinois, United States
Royal Cornhill Hospital, NHS Grampian, Aberdeen, United Kingdom
Thorax Center - Erasmus MC, Rotterdam, Netherlands
University Hospital Aachen, Aachen, Germany
Hôpital Pontchaillou, Rennes, France
University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein, Germany
Stanford University School of Medicine, Stanford, California, United States
Hennepin County Medical Center, Minneapolis, Minnesota, United States
University of Mississippi Medical Center, Jackson, Mississippi, United States
Severance Hospital, Seoul, Korea, Republic of
Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.